| Stem Cell Research and Therapy |
1 |
1 |
| Anaphylaxis |
0 |
0.97 |
| Graft Versus Host Disease and Transplant Complications |
0 |
0.97 |
| Hodgkin Lymphoma |
0 |
0.8 |
| Hematocrit |
0 |
0.67 |
| Bone Marrow Transplant |
0 |
0.63 |
| Transplantation |
0 |
0.58 |
| Cell Transplantation |
0 |
0.44 |
| Bone Marrow |
0 |
0.32 |
| Toxicology |
0 |
0.32 |
| Lymphoma |
0 |
0.31 |
| Bone |
0 |
0.22 |
| Cancer |
0 |
0.18 |
| Clinical Research |
0 |
0.13 |
| Mustard Vesicant |
0 |
0.13 |
| Graft Versus Host Disease |
0 |
0.1 |
| Blood |
0 |
0.09 |
| Board Certification |
0 |
0.09 |
| Graft |
0 |
0.09 |
| Dorsum |
0 |
0.04 |
| Europe |
0 |
0.04 |
| New York |
0 |
0.04 |
| Prophylaxis |
0 |
0.04 |